Product approval information for use in adults 18 through 65 years of age as immunotherapy for house dust mite- (HDM)-induced allergic rhinitis, with or without conjunctivitis, confirmed by in vitro testing for IgE antibodies to Dermatophagoides farinae or Dermatophagoides pteronyssinus house dust m
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/TRw61lv
No comments:
Post a Comment